Nifty

:

24625.05

Sensex

:

80364.49

198.20 (0.81%)
554.84 (0.70%)

Login

Nifty
Sensex

:
:

24625.05
80364.49

198.20 (0.81%)
554.84 (0.70%)

Strides Pharma Science Ltd.

Pharmaceuticals & Drugs - Global

Rating :

68/99

BSE: 532531 | NSE: STAR

Watchlist

NSE BSE

896.70

01-Sep-2025

Open
High
Low
Previous Close

864.5
914.45
864
863.70

Volume
Traded Value (lacs)
52 Week High
52 Week Low

345452
308270880.1
972
513.05

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

8,267.43
22.78
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

9,926.26
0.45%
3.11

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

4.78
6.60
7.37

EBITDA CAGR (%)

10 Years
5 Years
3 Years

7.68
4.94
15.67

PAT CAGR (%)

10 Years
5 Years
3 Years

13.60
2.84
132.95

P:E (Median)

8 Years
5 Years
3 Years

5.89
-
-

P:BV (Average)

8 Years
5 Years
3 Years

2.20
2.48
2.76

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.88
16.19
13.26

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS -7.76 390.5 51.9 67.8
P/E Ratio -115.55 2.30 17.28 13.23
Revenue 4051 4565 5123 5719
EBITDA 743 954 1101
Net Income -71 3593 479 625
ROA -1.1
P/B Ratio 2.31 2.75 2.33
ROE -3.26 17.1 19.1
FCFF 308 491 623
FCFF Yield 3.52 5.62 7.13
Net Debt 2199
BVPS 387.5 326.58 384.36

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 498.62 513.00 -2.80% 555.96 602.95 -7.79% 550.92 379.64 45.12% 609.96 552.60 10.38%
Expenses 431.39 447.95 -3.70% 488.03 491.53 -0.71% 476.82 378.17 26.09% 546.93 514.16 6.37%
EBITDA 67.23 65.05 3.35% 67.93 111.42 -39.03% 74.10 1.47 4,940.82% 63.03 38.44 63.97%
EBIDTM 13.48% 12.68% 12.22% 18.48% 13.45% 0.39% 10.33% 6.96%
Other Income 1.76 8.09 -78.24% 12.12 25.65 -52.75% 2.43 4.90 -50.41% 23.55 19.46 21.02%
Interest 30.45 40.51 -24.83% 29.36 39.05 -24.81% 34.21 36.24 -5.60% 50.15 41.72 20.21%
Depreciation 22.14 20.62 7.37% 22.37 21.92 2.05% 20.92 21.52 -2.79% 21.98 23.03 -4.56%
PBT 16.40 12.00 36.67% 28.32 76.02 -62.75% 21.38 -56.69 - 14.43 -6.84 -
Tax 3.06 1.17 161.54% 12.20 -2.83 - 6.44 3.60 78.89% -0.88 -0.10 -
PAT 13.35 10.83 23.27% 16.13 78.84 -79.54% 14.94 -60.29 - 15.31 -6.75 -
PATM 2.68% 2.11% 2.90% 13.08% 2.71% -15.88% 2.51% -1.22%
EPS 1.45 1.18 22.88% 1.75 8.55 -79.53% 1.62 -6.54 - 1.66 -0.73 -

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 1,119.74 1,054.34 6.20% 1,190.39 1,043.50 14.08% 1,153.67 1,005.77 14.71% 1,201.11 999.43 20.18%
Expenses 901.66 864.31 4.32% 972.52 839.19 15.89% 943.35 863.78 9.21% 965.30 846.30 14.06%
EBITDA 218.07 190.03 14.76% 217.87 204.31 6.64% 210.31 141.99 48.12% 235.81 153.13 53.99%
EBIDTM 19.48% 18.02% 18.30% 19.58% 18.23% 14.12% 19.63% 15.32%
Other Income 8.58 12.72 -32.55% 11.98 -13.55 - 5.62 8.75 -35.77% 28.41 35.85 -20.75%
Interest 47.46 72.52 -34.56% 50.32 71.10 -29.23% 52.18 69.71 -25.15% 82.15 78.59 4.53%
Depreciation 48.89 46.52 5.09% 48.86 47.94 1.92% 48.42 49.44 -2.06% 50.52 60.10 -15.94%
PBT 121.94 182.07 -33.03% 103.25 63.66 62.19% 112.89 21.52 424.58% 127.67 -114.64 -
Tax 16.45 19.02 -13.51% 20.76 12.52 65.81% 23.80 15.74 51.21% 21.20 -7.44 -
PAT 105.49 163.06 -35.31% 82.49 51.14 61.30% 89.09 5.78 1,441.35% 106.47 -107.20 -
PATM 9.42% 15.47% 6.93% 4.90% 7.72% 0.57% 8.86% -10.73%
EPS 10.81 364.62 -97.04% 8.92 1.98 350.51% 9.54 5.41 76.34% 10.14 -14.54 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 2,215.46 2,139.42 1,866.12 1,854.50 1,979.00 1,857.57 1,691.93 1,537.44 1,955.40 1,381.82 2,221.63 Net Sales Growth 8.17% 14.65% 0.63% -6.29% 6.54% 9.79% 10.05% -21.37% 41.51% -37.80% Cost Of Goods Sold 1,119.55 1,083.54 969.16 1,065.61 1,101.52 988.87 891.96 878.83 781.25 734.46 1,282.09 Gross Profit 1,095.91 1,055.89 896.96 788.89 877.49 868.70 799.97 658.61 1,174.15 647.36 939.55 GP Margin 49.47% 49.35% 48.07% 42.54% 44.34% 46.77% 47.28% 42.84% 60.05% 46.85% 42.29% Total Expenditure 1,943.17 1,888.05 1,724.32 1,771.77 1,902.37 1,698.33 1,487.47 1,403.10 1,815.21 1,269.85 1,953.73 Power & Fuel Cost - 36.00 47.90 45.54 43.76 45.82 44.53 39.77 33.08 25.82 74.12 % Of Sales - 1.68% 2.57% 2.46% 2.21% 2.47% 2.63% 2.59% 1.69% 1.87% 3.34% Employee Cost - 377.59 348.92 267.01 272.09 272.72 230.23 223.21 224.53 228.48 274.16 % Of Sales - 17.65% 18.70% 14.40% 13.75% 14.68% 13.61% 14.52% 11.48% 16.53% 12.34% Manufacturing Exp. - 191.36 196.84 189.99 151.87 153.93 140.73 121.12 106.78 108.28 103.48 % Of Sales - 8.94% 10.55% 10.24% 7.67% 8.29% 8.32% 7.88% 5.46% 7.84% 4.66% General & Admin Exp. - 89.19 62.35 84.63 136.15 115.41 120.08 74.99 79.18 80.46 111.16 % Of Sales - 4.17% 3.34% 4.56% 6.88% 6.21% 7.10% 4.88% 4.05% 5.82% 5.00% Selling & Distn. Exp. - 98.49 75.99 98.01 177.44 94.08 21.02 24.40 26.53 27.80 75.28 % Of Sales - 4.60% 4.07% 5.28% 8.97% 5.06% 1.24% 1.59% 1.36% 2.01% 3.39% Miscellaneous Exp. - 11.90 23.17 20.99 19.55 27.50 38.91 40.78 563.85 64.55 75.28 % Of Sales - 0.56% 1.24% 1.13% 0.99% 1.48% 2.30% 2.65% 28.84% 4.67% 1.51% EBITDA 272.29 251.37 141.80 82.73 76.63 159.24 204.46 134.34 140.19 111.97 267.90 EBITDA Margin 12.29% 11.75% 7.60% 4.46% 3.87% 8.57% 12.08% 8.74% 7.17% 8.10% 12.06% Other Income 39.86 57.26 67.42 99.82 123.48 117.08 93.07 114.61 1,001.72 169.06 109.12 Interest 144.17 145.91 139.38 138.68 74.24 65.34 66.84 54.09 81.97 71.96 102.62 Depreciation 87.41 84.61 87.41 93.62 104.37 99.34 94.24 83.00 114.77 70.01 102.69 PBT 80.53 78.11 -17.57 -49.76 21.51 111.64 136.44 111.85 945.18 139.06 171.70 Tax 20.82 18.93 1.34 -69.44 -158.68 33.40 16.17 -2.04 24.21 15.36 14.71 Tax Rate 25.85% 24.24% -5.84% 107.23% -737.70% 29.92% 11.85% -1.88% 2.64% 12.40% 10.15% PAT 59.73 59.16 -24.27 4.68 180.19 78.24 120.28 110.37 891.59 108.54 130.20 PAT before Minority Interest 59.73 59.16 -24.27 4.68 180.19 78.24 120.28 110.37 891.59 108.54 130.20 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 2.70% 2.77% -1.30% 0.25% 9.11% 4.21% 7.11% 7.18% 45.60% 7.85% 5.86% PAT Growth 163.94% - - -97.40% 130.30% -34.95% 8.98% -87.62% 721.44% -16.64% EPS 6.48 6.42 -2.63 0.51 19.54 8.49 13.05 11.97 96.70 11.77 14.12

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 4,664.91 4,565.34 3,890.13 3,688.39 3,070.25 3,315.87 2,981.12 3,108.33 3,344.37 3,826.22 2,862.19 Net Sales Growth 13.69% 17.36% 5.47% 20.13% -7.41% 11.23% -4.09% -7.06% -12.59% 33.68% Cost Of Goods Sold 1,921.30 1,979.96 1,749.05 1,626.88 1,502.32 1,332.79 1,122.48 1,085.20 1,378.84 1,281.17 1,502.29 Gross Profit 2,743.61 2,585.37 2,141.07 2,061.50 1,567.93 1,983.08 1,858.64 2,023.14 1,965.53 2,545.05 1,359.90 GP Margin 58.81% 56.63% 55.04% 55.89% 51.07% 59.81% 62.35% 65.09% 58.77% 66.52% 47.51% Total Expenditure 3,782.83 3,767.56 3,317.89 3,303.09 3,091.76 2,689.06 2,470.90 2,811.65 3,108.66 3,309.30 2,481.62 Power & Fuel Cost - 58.17 75.13 85.82 71.54 64.58 64.49 54.39 51.33 33.87 77.18 % Of Sales - 1.27% 1.93% 2.33% 2.33% 1.95% 2.16% 1.75% 1.53% 0.89% 2.70% Employee Cost - 862.76 737.05 732.02 646.91 550.15 442.56 329.44 434.05 419.16 357.69 % Of Sales - 18.90% 18.95% 19.85% 21.07% 16.59% 14.85% 10.60% 12.98% 10.95% 12.50% Manufacturing Exp. - 311.98 299.81 259.45 255.52 237.94 210.79 150.98 115.97 137.47 119.23 % Of Sales - 6.83% 7.71% 7.03% 8.32% 7.18% 7.07% 4.86% 3.47% 3.59% 4.17% General & Admin Exp. - 221.56 198.06 232.21 223.67 191.73 191.89 150.10 194.38 172.63 198.71 % Of Sales - 4.85% 5.09% 6.30% 7.29% 5.78% 6.44% 4.83% 5.81% 4.51% 6.94% Selling & Distn. Exp. - 298.20 215.03 263.65 331.30 223.22 137.07 111.22 208.85 161.12 129.57 % Of Sales - 6.53% 5.53% 7.15% 10.79% 6.73% 4.60% 3.58% 6.24% 4.21% 4.53% Miscellaneous Exp. - 34.93 43.76 103.06 60.51 88.65 301.61 930.33 725.25 1,103.88 129.57 % Of Sales - 0.77% 1.12% 2.79% 1.97% 2.67% 10.12% 29.93% 21.69% 28.85% 3.39% EBITDA 882.06 797.78 572.24 385.30 -21.51 626.81 510.22 296.68 235.71 516.92 380.57 EBITDA Margin 18.91% 17.47% 14.71% 10.45% -0.70% 18.90% 17.12% 9.54% 7.05% 13.51% 13.30% Other Income 54.59 63.76 49.85 135.22 133.40 59.44 66.70 322.90 920.64 398.08 102.37 Interest 232.11 248.85 280.22 261.14 176.74 150.06 155.72 79.29 196.24 183.10 168.17 Depreciation 196.69 192.26 213.64 243.25 233.01 206.29 187.79 171.85 193.93 198.69 131.25 PBT 465.75 420.42 128.22 16.11 -297.88 329.90 233.42 368.44 766.17 533.20 183.50 Tax 82.21 77.52 29.11 -55.30 -178.26 31.65 17.91 14.49 21.41 51.19 42.45 Tax Rate 17.65% 15.98% -47.86% 6010.87% 32.91% 8.48% 11.50% 3.71% 2.96% 10.30% 29.87% PAT 383.54 405.34 -120.20 -221.20 -460.21 352.32 143.62 370.31 681.31 399.38 113.21 PAT before Minority Interest 371.61 409.40 -143.90 -230.90 -474.25 341.61 137.82 375.57 701.18 445.58 99.68 Minority Interest -11.93 -4.06 23.70 9.70 14.04 10.71 5.80 -5.26 -19.87 -46.20 13.53 PAT Margin 8.22% 8.88% -3.09% -6.00% -14.99% 10.63% 4.82% 11.91% 20.37% 10.44% 3.96% PAT Growth 240.08% - - - - 145.31% -61.22% -45.65% 70.59% 252.78% EPS 41.60 43.96 -13.04 -23.99 -49.91 38.21 15.58 40.16 73.89 43.32 12.28

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 3,192.74 3,527.60 3,455.05 3,406.68 3,248.06 3,158.79 3,256.80 3,162.02 3,232.53 3,157.63 Share Capital 92.16 91.90 90.30 89.79 89.68 89.56 89.55 89.50 89.42 89.35 Total Reserves 3,100.06 3,432.61 3,345.33 3,314.44 3,153.66 3,063.50 3,159.68 3,063.45 3,134.25 3,062.51 Non-Current Liabilities 108.36 170.19 272.63 108.27 307.43 -37.31 -63.12 -34.41 795.22 876.55 Secured Loans 127.37 202.32 284.74 124.69 147.54 0.00 0.15 2.44 769.45 861.40 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 51.68 46.34 33.32 33.47 207.17 20.58 12.88 13.32 22.58 10.14 Current Liabilities 1,629.61 2,085.14 1,796.83 1,841.32 1,590.64 1,454.94 1,388.99 1,104.05 1,434.15 1,244.88 Trade Payables 484.85 543.76 643.44 643.80 735.20 489.87 509.40 390.72 470.56 497.17 Other Current Liabilities 169.73 236.78 153.81 108.43 136.11 93.08 49.36 73.51 290.27 195.69 Short Term Borrowings 951.93 1,284.28 984.57 1,068.64 693.50 852.45 808.80 601.59 647.44 543.38 Short Term Provisions 23.10 20.33 15.00 20.45 25.82 19.54 21.44 38.22 25.87 8.65 Total Liabilities 4,930.71 5,782.93 5,524.51 5,356.27 5,146.13 4,576.42 4,582.67 4,231.66 5,461.90 5,279.06 Net Block 756.02 735.60 584.30 604.09 576.66 578.35 496.73 497.96 1,123.76 983.58 Gross Block 1,479.95 1,446.15 1,182.95 1,128.61 1,012.07 923.74 746.47 676.58 1,339.89 1,080.89 Accumulated Depreciation 723.93 710.55 598.65 524.52 435.41 345.39 249.74 178.62 216.13 97.31 Non Current Assets 2,785.21 3,371.76 3,398.10 3,381.03 3,402.26 3,180.89 2,919.09 2,732.11 2,882.74 2,633.43 Capital Work in Progress 105.68 107.48 55.38 55.72 110.67 112.25 122.46 143.86 157.75 180.09 Non Current Investment 1,847.69 2,363.59 2,491.77 2,399.76 2,462.48 2,242.91 2,071.47 1,531.19 1,310.77 1,307.94 Long Term Loans & Adv. 50.88 145.96 245.47 304.95 247.32 237.29 223.27 154.76 204.04 154.66 Other Non Current Assets 14.02 7.52 8.92 3.70 5.13 10.10 5.16 404.35 86.41 7.16 Current Assets 2,145.50 2,411.18 2,126.40 1,975.25 1,743.86 1,395.53 1,663.59 1,499.54 2,579.16 2,645.62 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 154.29 311.48 1,279.54 1,139.10 Inventories 431.71 498.07 490.76 513.06 689.08 462.82 473.34 269.63 409.53 379.23 Sundry Debtors 1,452.93 1,565.04 1,307.78 1,296.32 821.66 655.61 582.56 449.37 540.68 692.40 Cash & Bank 30.50 115.10 85.58 14.45 73.04 109.90 180.81 79.79 94.92 94.34 Other Current Assets 230.36 126.51 92.60 83.67 160.07 167.20 272.58 389.29 254.49 340.55 Short Term Loans & Adv. 118.76 106.46 149.68 67.75 80.42 89.14 123.06 175.88 122.37 95.54 Net Current Assets 515.89 326.04 329.58 133.92 153.22 -59.42 274.59 395.49 1,145.00 1,400.74 Total Assets 4,930.71 5,782.94 5,524.50 5,356.28 5,146.12 4,576.42 4,582.68 4,231.65 5,461.90 5,279.05

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,551.83 2,125.57 2,212.26 2,359.23 2,776.66 2,527.42 2,648.70 2,463.66 2,748.82 2,657.87 Share Capital 92.16 91.90 90.30 89.79 89.68 89.56 89.55 89.50 89.42 89.35 Total Reserves 2,459.16 2,030.57 2,102.54 2,266.99 2,682.26 2,432.13 2,551.59 2,365.10 2,650.55 2,562.75 Non-Current Liabilities 601.61 621.44 1,210.30 965.72 1,264.45 813.65 2,342.88 2,067.29 2,048.67 2,760.03 Secured Loans 558.47 618.40 1,040.81 744.86 873.43 601.79 1,806.45 1,551.09 1,622.87 2,614.88 Unsecured Loans 12.78 53.10 98.98 90.77 9.15 2.12 0.06 0.23 14.84 12.13 Long Term Provisions 113.94 91.63 73.42 64.28 246.50 63.95 52.24 16.55 25.19 14.45 Current Liabilities 2,591.52 2,879.26 2,990.20 3,411.68 2,738.35 2,544.86 2,662.24 1,899.30 3,103.87 1,891.98 Trade Payables 1,032.50 851.59 982.34 1,071.52 1,134.20 797.75 888.99 712.07 774.09 775.40 Other Current Liabilities 307.41 341.57 527.89 697.18 421.00 354.49 248.12 129.98 819.08 347.93 Short Term Borrowings 1,136.36 1,574.15 1,330.76 1,496.53 1,023.84 1,228.78 1,339.02 944.39 1,393.96 700.48 Short Term Provisions 115.25 111.94 149.20 146.43 159.31 163.84 186.11 112.86 116.73 68.19 Total Liabilities 5,779.59 5,572.41 6,373.38 6,760.72 6,816.80 5,953.17 7,806.77 6,584.90 8,034.86 7,360.09 Net Block 1,888.12 1,853.18 2,298.42 2,333.45 2,151.13 2,025.85 3,570.13 2,903.00 2,909.03 2,678.68 Gross Block 2,897.25 2,873.18 3,324.82 3,231.69 2,841.28 2,534.38 4,049.05 3,229.03 3,186.12 2,825.43 Accumulated Depreciation 1,009.14 1,020.00 1,026.40 898.24 690.15 508.53 478.92 326.03 277.09 146.75 Non Current Assets 2,680.68 2,603.41 3,130.03 3,398.88 3,999.57 3,581.05 4,758.05 4,101.31 4,243.05 3,845.20 Capital Work in Progress 206.76 161.89 150.98 291.08 447.37 412.95 453.03 620.29 780.18 814.88 Non Current Investment 339.71 196.93 438.96 540.34 666.23 503.24 494.34 350.08 315.66 127.19 Long Term Loans & Adv. 140.19 256.13 217.18 210.58 185.80 210.82 223.69 197.22 222.56 201.83 Other Non Current Assets 94.73 123.38 11.91 10.26 549.04 428.19 16.86 30.72 15.62 22.62 Current Assets 3,098.91 2,969.00 3,135.25 3,361.83 2,817.23 2,372.11 3,048.72 2,483.59 3,791.82 3,514.89 Current Investments 69.50 105.76 50.84 0.00 99.41 118.97 284.75 311.48 1,279.54 1,213.76 Inventories 1,277.57 1,126.24 1,146.51 1,173.80 1,200.70 782.54 874.16 552.02 732.80 613.14 Sundry Debtors 1,202.94 1,141.87 1,299.40 1,207.30 1,110.59 931.69 987.18 882.18 995.91 1,032.97 Cash & Bank 136.78 191.17 315.96 187.35 179.76 237.10 516.65 303.33 329.48 311.59 Other Current Assets 412.12 228.99 169.21 647.90 226.76 301.81 385.98 434.59 454.09 343.44 Short Term Loans & Adv. 135.92 174.97 153.34 145.49 128.54 218.24 249.11 295.75 244.39 97.54 Net Current Assets 507.39 89.74 145.05 -49.84 78.89 -172.75 386.48 584.29 687.95 1,622.91 Total Assets 5,779.59 5,572.41 6,265.28 6,760.71 6,816.80 5,953.16 7,806.77 6,584.90 8,034.87 7,360.09

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 421.48 -14.01 241.74 -282.69 282.76 137.63 39.97 65.59 411.74 83.08 PBT 2,905.14 40.99 -64.76 21.51 111.64 136.44 108.33 915.80 123.90 144.91 Adjustment -2,622.75 250.90 172.87 75.17 114.15 130.28 90.19 -670.77 193.49 156.46 Changes in Working Capital 16.58 -359.60 33.81 -400.77 -109.81 -96.91 -121.04 -161.75 131.16 -168.93 Cash after chg. in Working capital 298.97 -67.71 141.92 -304.09 115.97 169.81 77.48 83.28 448.55 132.44 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 122.52 53.71 99.82 21.41 166.79 -32.17 -37.52 -17.68 -36.81 -49.36 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -137.59 -69.56 -182.58 18.78 -275.64 62.83 -166.06 447.36 -344.05 -1,063.90 Net Fixed Assets -32.00 -315.30 -54.00 -61.59 -86.75 -167.06 -48.49 677.20 -236.66 -535.93 Net Investments 515.90 128.18 -92.01 62.72 -219.57 -17.15 -383.09 747.64 -143.27 -1,478.58 Others -621.49 117.56 -36.57 17.65 30.68 247.04 265.52 -977.48 35.88 950.61 Cash from Financing Activity -370.32 93.34 10.82 250.73 -48.64 -203.56 123.26 -706.77 -67.24 1,570.84 Net Cash Inflow / Outflow -86.42 9.77 69.98 -13.18 -41.52 -3.09 -2.83 -193.82 0.45 590.03 Opening Cash & Equivalents 92.75 82.11 12.12 25.30 66.82 69.91 72.30 280.52 818.84 264.05 Closing Cash & Equivalent 6.33 92.75 82.11 12.12 25.30 66.82 69.47 72.30 280.52 818.84

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 684.37 701.07 44.41 -257.81 481.44 204.79 60.05 187.07 288.14 73.25 PBT 3,675.03 -62.72 -267.63 -652.51 289.38 48.51 344.37 705.80 497.14 146.44 Adjustment -2,893.97 818.27 682.19 582.27 363.31 527.49 94.59 -274.51 190.92 345.56 Changes in Working Capital -163.72 -78.73 -457.80 -189.90 -328.05 -326.23 -323.14 -190.66 -341.30 -341.71 Cash after chg. in Working capital 617.34 676.82 -43.23 -260.14 324.64 249.76 115.82 240.63 346.76 150.29 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 67.04 24.25 87.64 2.33 156.80 -44.98 -55.76 -53.56 -58.62 -77.04 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -89.69 -150.25 302.47 -118.73 -520.82 1,306.16 -148.49 582.59 -686.69 -2,224.83 Net Fixed Assets -32.00 -315.30 -54.00 -61.59 -86.75 -167.06 -48.49 677.20 -236.66 -535.93 Net Investments 515.90 128.18 -92.01 62.72 -219.57 -17.15 -383.09 747.64 -143.27 -1,478.58 Others -573.59 36.87 448.48 -119.86 -214.50 1,490.37 283.09 -842.25 -306.76 -210.32 Cash from Financing Activity -642.58 -693.32 -213.92 421.32 -15.80 -1,709.45 194.27 -1,015.69 338.21 2,943.94 Net Cash Inflow / Outflow -47.90 -142.51 132.96 44.77 -55.18 -198.50 105.83 -246.03 -60.33 792.35 Opening Cash & Equivalents 161.02 303.50 170.73 125.83 182.23 365.89 256.16 515.08 1,110.74 298.91 Closing Cash & Equivalent 112.56 161.02 303.50 170.73 125.83 182.23 365.89 256.16 515.08 1,110.74

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 346.37 383.52 380.46 379.13 361.65 352.04 362.84 352.29 360.50 352.77 ROA 1.10% -0.43% 0.09% 3.43% 1.61% 2.63% 2.50% 18.40% 2.02% 2.98% ROE 1.76% -0.70% 0.14% 5.42% 2.45% 3.76% 3.45% 27.96% 3.40% 5.63% ROCE 4.71% 2.34% 1.56% 2.18% 4.35% 5.03% 4.15% 23.18% 4.10% 7.52% Fixed Asset Turnover 1.46 1.42 1.60 1.85 1.92 2.03 2.16 1.94 1.14 2.51 Receivable days 257.44 280.95 256.27 195.32 145.14 133.56 122.49 92.40 162.86 77.91 Inventory Days 79.31 96.70 98.79 110.86 113.17 100.98 88.19 63.39 104.17 43.92 Payable days 173.25 223.56 220.46 228.47 226.09 127.51 117.56 116.72 143.54 64.74 Cash Conversion Cycle 163.51 154.10 134.60 77.70 32.22 107.02 93.13 39.07 123.49 57.08 Total Debt/Equity 0.36 0.46 0.39 0.37 0.27 0.27 0.25 0.19 0.50 0.49 Interest Cover 1.54 0.84 0.53 1.29 2.71 3.04 3.00 12.17 2.72 2.41

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 276.83 230.95 242.83 262.48 309.09 281.55 294.94 274.26 306.41 296.83 ROA 7.21% -2.41% -3.52% -6.99% 5.35% 2.00% 5.22% 9.59% 5.79% 2.03% ROE 17.52% -6.67% -10.15% -18.49% 12.91% 5.34% 14.74% 27.00% 16.53% 5.25% ROCE 16.56% 3.47% -0.49% -9.49% 11.17% 6.01% 8.65% 16.07% 10.75% 7.54% Fixed Asset Turnover 2.46 1.96 1.91 1.75 2.04 1.50 1.17 1.04 1.27 1.47 Receivable days 60.35 73.17 73.25 79.41 68.09 70.88 79.95 102.49 96.77 90.73 Inventory Days 61.86 68.12 67.80 81.35 66.13 61.20 61.00 70.11 64.20 52.34 Payable days 173.66 191.36 230.40 267.95 264.54 138.58 146.59 116.23 117.33 75.51 Cash Conversion Cycle -51.45 -50.07 -89.35 -107.20 -130.32 -6.50 -5.64 56.37 43.64 67.55 Total Debt/Equity 0.70 1.14 1.27 1.18 0.76 0.78 1.22 1.03 1.35 1.34 Interest Cover 2.96 0.59 -0.10 -2.69 3.49 2.00 5.92 4.68 3.71 1.85

Top Investors:

quant mutual fund - quant business cycle fund

route one offshore master fund, l.p.

route one fund i, l.p.

sbi life insurance co. ltd

morgan stanley asia (singapore) pte. - odi

authum investment and infrastructure limited

axis mutual fund trustee limited a/c axis mutual f

mukul mahavir agrawal

oman india joint investment fund ii

Annual Reports:

News Update:

Strides Pharma Scien - Quarterly Results
29th Jul 2025, 12:33 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback